VAERS Reports U003464

VAERS 2092652

MERCK & CO. INC. · HEP A (VAQTA) · Charge U003464

schwer

Staat: PA
Alter: 10,0
Geschlecht: M
Eingang: 07.02.2022
Impfdatum: 07.02.2022
Beginn: 07.02.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Dizziness Loss of consciousness Pallor Urinary incontinence

Symptomtext

Child showed signs of anxiety prior to vaccines so he sat on his guardian's lap, child nervous during vaccines but allowing vaccines without verbal protest. After last vaccine to be given ( Pediatric Pfizer) child in guardians arms lost consciousness for less than 5 seconds, child slumped in guardians arms, turned pale, loss control of bladder, then came around and began to lift head and stand in guardians arms. Child was able to assist with sitting and laying on stirrup medical bed in room with use of step and assistance of nurse and guardian, child laid down and rested for 10 minutes, was given sips of water and instructed on breathing and after 10 minutes given bite to eat of fruit breakfast bar, child laid back down, instructed to and able to follow commands to pumping hands for increased circulation for approximately 3 minutes. Child stated he was feeling better, child sat up on bed with guardian and nurse present for approximately 10 minutes used distraction conversation with guardian about family child participated and smiled and laughed with conversation, child displayed signs of improvement with conversation, self supporting bodily movements, improved pallor and hands warm to touch.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: none
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2304837

MERCK & CO. INC. · HEP A (VAQTA) · Charge U003464

gering

Staat: VA
Alter: -
Geschlecht: U
Eingang: 01.06.2022
Impfdatum: 06.05.2022
Beginn: 06.05.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

This spontaneous report was received from a registered nurse, concerning a patient of unknown age and gender. Information regarding the patient's pertinent medical history, concurrent conditions and concomitant medications was not provided. On 06-MAY-2022, the patient was vaccinated with a dose of an expired Hepatitis A Vaccine, Inactivated (VAQTA) for prophylaxis, lot number #U003464 and expiration date 02-MAY-2022 (strength, dose, frequency and route of administration were not reported). No adverse events were reported. This is one of 2 reports received from the same reporter (MARRS #US-009507513-2205USA003680) ; Sender's Comments: US-009507513-2205USA003680:Case Number: 02164360

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2301734

MERCK & CO. INC. · HEP A (VAQTA) · Charge U003464

gering

Staat: IL
Alter: -
Geschlecht: U
Eingang: 30.05.2022
Impfdatum: 04.05.2022
Beginn: 04.05.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

No additional adverse events reported.; Nurse reporting the administration of expired VAQTA and inquiring viability information pertaining to administration of expired dose.; This spontaneous report has been received from a registered nurse, referring to a patient of unknown age and gender. Information regarding the patient's pertinent medical history, concurrent condition and concomitant medication was not provided. On 04-MAY-2022, the patient was vaccinated with expired hepatitis a vaccine, inactivated(VAQTA) (lot # U003464 with expiration date: 02-MAY-2022, 0.5 milliliter, strength and route were unknown) for prophylaxis (Expired product administered). The reporter inquired viability information pertaining to administration of expired dose. No additional adverse events reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2299548

MERCK & CO. INC. · HEP A (VAQTA) · Charge U003464

gering

Staat: VA
Alter: -
Geschlecht: U
Eingang: 28.05.2022
Impfdatum: 06.05.2022
Beginn: 06.05.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

No adverse event; Expired vaccines, with the same lot and expiration date, were administered to two different patients; This spontaneous report was received from a healthcare professional, concerning a patient of unknown age and gender. Information regarding the patient's pertinent medical history, concurrent conditions and concomitant medications was not provided. On 06-MAY-2022, the patient received vaccination with an expired Hepatitis A Vaccine, Inactivated (VAQTA) for prophylaxis, lot number #U003464 and expiration date 02-MAY-2022 (strength, dose, frequency and route of administration were not reported). No adverse events were reported. This is one of 2 reports received from the same reporter (MARRS #US-009507513-2205USA003700) ; Sender's Comments: US-009507513-2205USA003700:Case Number: 02164360

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2288953

MERCK & CO. INC. · HEP A (VAQTA) · Charge U003464

gering

Staat: MO
Alter: 2,0
Geschlecht: F
Eingang: 21.05.2022
Impfdatum: 10.05.2022
Beginn: 10.05.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

No additional AE reported.; Nurse reported that VAQTA with an expiration date of 5/2/2022 was administered to a patient today (5/10/2022). She was requesting guidance on this. No additional AE reported. No PQC reported. No further information was provided.; This spontaneous report has been received from a nurse and refers to a 2-year-old female patient. The patient's medical history, current conditions, concomitant therapies, and previous drugs reactions or allergies were not reported. On 10-MAY-2022, the patient was vaccinated with an expired hepatitis a vaccine, inactivated (VAQTA) intramuscular injection, at a dose of 0.5 milliliter, lot number U003464, expiration date: 02-MAY-2022 for prophylaxis (vaccination scheme, route of administration and anatomical site of application were not reported) (expired product administered). No adverse event was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2268436

MERCK & CO. INC. · HEP A (VAQTA) · Charge U003464

gering

Staat: CA
Alter: -
Geschlecht: U
Eingang: 10.05.2022
Impfdatum: 05.05.2022
Beginn: 05.05.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

No additonal AE's; expired dose of VAQTA that was administered to a patient; This spontaneous report was received from a registered nurse and refers to a patient of unknown age and gender. No information regarding the patient's medical history, concurrent conditions or concomitant therapies was provided. On 05-MAY-2022, the patient was vaccinated with hepatitis a vaccine, inactivated (VAQTA) pre-filled syringe, lot #U003464, expiration date: 02-MAY-2022 (strength, site and route of administration were not provided) for prophylaxis (Expired product administered). No adverse events were reported (No adverse event).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1775901

MERCK & CO. INC. · HEP A (VAQTA) · Charge U003464

gering

Staat: VA
Alter: 15,0
Geschlecht: U
Eingang: 11.10.2021
Impfdatum: 29.09.2021
Beginn: 29.09.2021
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

No adverse event Product storage error

Symptomtext

No Additional AE's reported; She reported that GARD ASIL 9 and V AQT A were administered to a patient today that had undergone temperature excursion; This spontaneous report was received from a medical assistant referring to a 15-year-old patient of unknown gender. The patient's pertinent medical history, drug reactions or allergies and concomitant medications were not reported. On 29-SEP-2021, the patient was vaccinated with hepatitis A vaccine, inactivated (VAQTA) (lot number U003464 has been verified to be valid, expiration date reported and established as 02-MAY-2022) and hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) (lot number T039467 has been verified to be valid, expiration date reported and established as 20-MAY-2023) (doses, routes of administration, anatomical sites of vaccination, dose numbers and vaccine schemes were not reported). Both vaccines were administered as prophylaxis. It was reported that the vaccines undergone a temperature excursion of 1.3 degrees Celsius (C) during a time frame of 15 hours and 43 minutes (product storage error). There was no previous temperature excursion, and no additional adverse events were reported (no adverse event).

Weitere VAERSDATA-Felder

Praegender Schweregrund: No adverse event
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -